Fig. 8

The miR-504/FZD7 ratio is a prognostic indicator in GBM. a Kaplan–Meier assessment of the association between the miR-504/FZD7 ratio and overall survival of patients with GBM in TCGA. b–d Prognostic significance of the miR-504/FZD7 ratio in cohorts stratified by age (b), sex (c), and MGMT promoter status (d). e Kaplan–Meier analysis of survival of chemotherapy-treated patients with GBM based on the miR-504/FZD7 ratio. f Comparison of 1–5-year survival rates between high and low miR-504/FZD7 ratio groups in chemotherapy-treated patients with GBM. g Kaplan–Meier analysis of overall survival according to the miR-504/FZD7 ratio of standard radiotherapy–treated patients with GBM from TCGA. h Comparison of 1–5-year survival rates between high and low miR-504/FZD7 ratio groups in standard radiotherapy–treated patients with GBM. *P < 0.05, **P < 0.01, ***P < 0.001